Publications

• Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium.
  J Natl Cancer Inst Volume: 116 Page(s): 1721 - 1729
  11/01/2024 Authors: Schafer ES; Rushing T; Crews KR; Annesley C; Colace SI; Kaiser N; Pommert L; Ramsey LB; Sabnis HS; Wong K
• Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.
  Nat Commun Volume: 14 Page(s): 6209
  10/05/2023 Authors: Mumme H; Thomas BE; Bhasin SS; Krishnan U; Dwivedi B; Perumalla P; Sarkar D; Ulukaya GB; Sabnis HS; Park SI
• RESPONSE TO REINDUCTION CHEMOTHERAPY IN FIRST RELAPSE PEDIATRIC B-ALL: A SINGLE-INSTITUTION REVIEW
  Volume: 70 Page(s): S49 - S50
  06/01/2023 Authors: Digiandomenico S; Summers R; Bennett A; Sabnis H; Aumann W
• Inflammation or Infiltration? Infiltrative Cardiovascular Chloroma Presenting With Syncope and Heart Block.
  Circ Cardiovasc Imaging Volume: 16 Page(s): e014532
  01/01/2023 Authors: Wilson HC; Hashemi S; Sabnis HS; Hong AL; Michelfelder EC
• Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia.
  J Immunother Cancer Volume: 10
  06/01/2022 Authors: Gilbert JR; Sabnis HS; Radzievski R; Doxie DB; DeRyckere D; Castellino SM; Dhodapkar K
• ENRICHMENT OF HIGH-RISK INNATE IMMUNE CELLS IN HISPANIC AND BLACK CHILDREN WITH B-ALL
  Volume: 69
  06/01/2022 Authors: Gilbert J; Sabnis H; Radzievski R; Doxie D; DeRyckere D; Castellino S; Dhodapkar K
• Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
  J Clin Oncol Volume: 39 Page(s): 3822 - 3828
  12/01/2021 Authors: Sabnis HS; Shulman DS; Mizukawa B; Bouvier N; Zehir A; Fangusaro J; Fabrizio VA; Whitlow C; Winchester M; Agresta L
• Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
  Br J Haematol Volume: 194 Page(s): 549 - 553
  08/01/2021 Authors: Patel PA; Lapp SA; Grubbs G; Edara VV; Rostad CA; Stokes CL; Pauly MG; Anderson EJ; Piantadosi A; Suthar MS
• Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia.
  Antioxidants (Basel) Volume: 10
  06/15/2021 Authors: Wang Z; Mi T; Bradley HL; Metts J; Sabnis H; Zhu W; Arbiser J; Bunting KD
• USE OF HYPOMETHYLATING AGENTS IN RELAPSED/REFRACTORY PEDIATRIC ACUTE MYELOID LEUKEMIA
  Volume: 68 Page(s): S52 - S53
  06/01/2021 Authors: Sabnis H; Raikar S; Bennett A; MacDonald K; Watkins B; Woods W; Keller F
• Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias.
  BMC Cancer Volume: 21 Page(s): 474
  04/29/2021 Authors: Smith SM; Sabnis HS; Lewis RW; Effinger KE; Bergsagel J; Patterson B; Mertens A; Sakamoto KM; Schapira L; Castellino SM
• Clinical features and antibody response of two pediatric patients presenting with new-onset acute myeloid leukemia and concomitant severe COVID-19.
  Volume: 26
  09/01/2020 Authors: Patel PA; Rostad CA; Lapp SA; Stokes CL; Pauly MG; Anderson EJ; Sabnis HS
• A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes.
  Leuk Res Volume: 96 Page(s): 106421
  09/01/2020 Authors: Sabnis HS; Minson KA; Monroe C; Allen K; Metts JL; Cooper TM; Woods WG; Castellino SM; Keller FG
• Severe COVID-19 disease in two pediatric oncology patients.
  Pediatr Blood Cancer Volume: 67 Page(s): e28432
  09/01/2020 Authors: Stokes CL; Patel PA; Sabnis HS; Mitchell SG; Yildirim IB; Pauly MG
• Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor.
  Pediatr Hematol Oncol Volume: 37 Page(s): 438 - 444
  08/01/2020 Authors: Fridlyand DM; Keller FG; Sabnis HS; Patterson BC; Gadde JA; Peragallo JH; Biousse V; Wechsler DS
• Targeted therapies for children and young adults with cancer: Single-patient use (SPU) experience at three large pediatric cancer programs
  Volume: 80 Page(s): 69 - 70
  07/01/2020 Authors: Sabnis H; Mizukawa B; Glade-Bender J; Fangusaro J; Roberts S; Whitlow C; Winchester M; O'Brien M; Agresta L; Turpin B
• Screening practices for late effects in pediatric patients on tyrosine kinase inhibitors.
  Volume: 38
  05/20/2020 Authors: Smith SM; Sabnis HS; Lewis RW; Effinger KE; Bergsagel DJ; Patterson B; Mertens AC; Sakamoto K; Schapira L; Castellino SM
• Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.
  Lancet Oncol Volume: 20 Page(s): 1710 - 1718
  12/01/2019 Authors: Laetsch TW; Myers GD; Baruchel A; Dietz AC; Pulsipher MA; Bittencourt H; Buechner J; De Moerloose B; Davis KL; Nemecek E
• Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia.
  Br J Haematol Volume: 185 Page(s): 795 - 799
  05/01/2019 Authors: Sabnis HS; Keenum C; Lewis RW; Patterson B; Bergsagel J; Effinger KE; Silverman E; Mertens AC; Castellino SM
• Acute Myeloid Leukemia in an Infant with t(8;19)(p11.2;q13) Translocation: Case Report and a Review of the Literature.
  Case Rep Hematol Volume: 2019 Page(s): 4198415
  01/01/2019 Authors: Eason AC; Bunting ST; Peterson JF; Saxe D; Sabnis HS
• ALLOPURINOL USE WITH 6-MERCAPTOPURINE IN MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
  PEDIATRIC BLOOD & CANCER Volume: 65
  06/01/2018 Authors: Phillips L; Minson K; Castellino S; Bergsagel J; Lew G; Sabnis H; Pauly M; Keller F
• Factors affecting same-day cancelation of outpatient pediatric oncologic procedural sedation.
  Pediatr Hematol Oncol Volume: 35 Page(s): 309 - 315
  01/01/2018 Authors: Grunwell JR; Long LD; Bryan LN; Kelley T; Sabnis HS; Simon HK; Kamat PP
• Absence of Silent Inactivation Using Intravenous Pegaspargase in Pediatric Acute Lymphoblastic Leukemia
  BLOOD Volume: 130
  12/07/2017 Authors: Kumar S; Travers CD; Bergsagel J; Keller FG; Pauly M; Sabnis H; Castellino SM; Lew G
• Growth Disturbances in Pediatric Patients Receiving Long-Term Tyrosine Kinase Inhibitor Therapy
  BLOOD Volume: 130
  12/07/2017 Authors: Sabnis H; Keenum C; Lewis RW; Silverman EA; Patterson B; Effinger KE; Bergsagel J; Mertens A; Castellino SM
• Intensified induction therapy with reduced total anthracycline exposure in pediatric low-risk acute myeloid leukemia.
  Volume: 35
  05/20/2017 Authors: Minson KA; Herring C; Metts J; Sabnis H; Cooper TM; Woods WG; Keller FG
• Targeting MYC Dependence by Metabolic Inhibitors in Cancer.
  Genes (Basel) Volume: 8
  03/31/2017 Authors: Sabnis HS; Somasagara RR; Bunting KD
• Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine.
  Leuk Res Volume: 50 Page(s): 132 - 140
  11/01/2016 Authors: Sabnis HS; Bradley HL; Tripathi S; Yu W-M; Tse W; Qu C-K; Bunting KD
• Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
  Pediatr Blood Cancer Volume: 63 Page(s): 1667 - 1670
  09/01/2016 Authors: Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
• PRESCRIBED DOSES OF MAINTENANCE ORAL CHEMOTHERAPY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA VARIES BY PATIENT RACE
  PEDIATRIC BLOOD & CANCER Volume: 63 Page(s): S43 - S44
  06/01/2016 Authors: Pauly M; Lee B; Travers C; Lew G; Sabnis H; Castellino S
• Capillary nano-immunoassay for Akt 1/2/3 and 4EBP1 phosphorylation in acute myeloid leukemia.
  J Transl Med Volume: 12 Page(s): 166
  06/12/2014 Authors: Sabnis H; Bradley HL; Bunting ST; Cooper TM; Bunting KD
• Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.
  Pediatr Blood Cancer Volume: 61 Page(s): 810 - 814
  05/01/2014 Authors: Nickel RS; Keller F; Bergsagel J; Cooper T; Daves M; Sabnis H; Lew G
• Nanoproteomic assays on hematopoietic stem cells.
  Methods Mol Biol Volume: 1185 Page(s): 165 - 177
  01/01/2014 Authors: Bradley HL; Sabnis H; Pritchett D; Bunting KD
• Rapid nano-immunoassay for evaluation of mTOR pathway activation in acute myeloid leukemia.
  MOLECULAR CANCER THERAPEUTICS Volume: 12
  11/01/2013 Authors: Sabnis H; Bradley H; Cooper T; Bunting K
• Molecular targets for the treatment of juvenile myelomonocytic leukemia.
  Adv Hematol Volume: 2012 Page(s): 308252
  01/01/2012 Authors: Liu X; Sabnis H; Bunting KD; Qu C-K
• CLINICAL AND LABORATORY FEATURES OF JMML: REPORT FROM NORTH AMERICAN JMML PROJECT
  PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 927 - 927
  06/01/2011 Authors: Sabnis H; Castleberry R; Emanuel P; Cooper T
• Leukocyte adhesion deficiency-III in an African-American patient.
  Pediatr Blood Cancer Volume: 55 Page(s): 180 - 182
  07/15/2010 Authors: Sabnis H; Kirpalani A; Horan J; McDowall A; Svensson L; Cooley A; Merck T; Jobe S; Hogg N; Briones M
• Two mutations in the KINDLIN3 gene of a new leukocyte adhesion deficiency III patient reveal distinct effects on leukocyte function in vitro.
  Blood Volume: 115 Page(s): 4834 - 4842
  06/10/2010 Authors: McDowall A; Svensson L; Stanley P; Patzak I; Chakravarty P; Howarth K; Sabnis H; Briones M; Hogg N
• Visual diagnosis: sepsis, respiratory distress, and a persistent right lung opacification in a newborn.
  Pediatr Rev Volume: 30 Page(s): 453 - 456
  11/01/2009 Authors: Sabnis H; Sood BG; Zilberman M; Becker C